Screener
USANA Health Sciences USNA Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Earnings from operations | 13,874 | 15,671 |
| Other income (expense): | ||
| Interest income | 437 | 723 |
| Interest expense | (240) | (411) |
| Other, net | 1,394 | 756 |
| Other income (expense), net | 1,591 | 1,068 |
| Earnings before income taxes | 15,465 | 16,739 |
| Income taxes | 8,506 | 7,449 |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's interest expense?
- USANA Health Sciences (USNA) reported interest expense of $240K in Q1 2026.
- How has USANA Health Sciences's interest expense changed year-over-year?
- USANA Health Sciences's interest expense decreased by 41.6% year-over-year, from $411K to $240K.
- What is the long-term trend for USANA Health Sciences's interest expense?
- Over 3 years (2022 to 2025), USANA Health Sciences's interest expense has grown at a 63.7% compound annual growth rate (CAGR), from $192K to $842K.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about USANA Health Sciences's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude